139 related articles for article (PubMed ID: 22284360)
1. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H
Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360
[TBL] [Abstract][Full Text] [Related]
2. A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry.
Baleux F; Loureiro-Morais L; Hersant Y; Clayette P; Arenzana-Seisdedos F; Bonnaffé D; Lortat-Jacob H
Nat Chem Biol; 2009 Oct; 5(10):743-8. PubMed ID: 19734912
[TBL] [Abstract][Full Text] [Related]
3. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
Neffe AT; Meyer B
Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
[No Abstract] [Full Text] [Related]
4. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
5. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
6. CD4 mimics targeting the mechanism of HIV entry.
Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
[TBL] [Abstract][Full Text] [Related]
7. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
[TBL] [Abstract][Full Text] [Related]
8. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
9. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
10. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
Caporuscio F; Tafi A; González E; Manetti F; Esté JA; Botta M
Bioorg Med Chem Lett; 2009 Nov; 19(21):6087-91. PubMed ID: 19783140
[TBL] [Abstract][Full Text] [Related]
11. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
12. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
Mori T; Boyd MR
Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
[TBL] [Abstract][Full Text] [Related]
13. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.
Arthos J; Cicala C; Selig SM; White AA; Ravindranath HM; Van Ryk D; Steenbeke TD; Machado E; Khazanie P; Hanback MS; Hanback DB; Rabin RL; Fauci AS
Virology; 2002 Jan; 292(1):98-106. PubMed ID: 11878912
[TBL] [Abstract][Full Text] [Related]
14. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
[TBL] [Abstract][Full Text] [Related]
15. A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120.
Quinlan BD; Joshi VR; Gardner MR; Ebrahimi KH; Farzan M
J Virol; 2014 Mar; 88(6):3353-8. PubMed ID: 24390333
[TBL] [Abstract][Full Text] [Related]
16. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
Kazmierski WM; Kenakin TP; Gudmundsson KS
Chem Biol Drug Des; 2006 Jan; 67(1):13-26. PubMed ID: 16492145
[TBL] [Abstract][Full Text] [Related]
17. HIV and SIV gp120 binding does not predict coreceptor function.
Baik SS; Doms RW; Doranz BJ
Virology; 1999 Jul; 259(2):267-73. PubMed ID: 10388651
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
19. Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.
Savarino A; Bensi T; Chiocchetti A; Bottarel F; Mesturini R; Ferrero E; Calosso L; Deaglio S; Ortolan E; Buttò S; Cafaro A; Katada T; Ensoli B; Malavasi F; Dianzani U
FASEB J; 2003 Mar; 17(3):461-3. PubMed ID: 12551845
[TBL] [Abstract][Full Text] [Related]
20. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
Mbemba E; Benjouad A; Saffar L; Gattegno L
Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
